IONIS PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Ionis Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $2.2M, a 90.7% decline year-over-year.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $478M, a 25.8% decline from 2023.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $644M.
  • Ionis Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$55.3M, a 122% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

IONIS PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $2.2M -$21.4M -90.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q1 2024 $23.6M -$469M -95.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q1 2023 $492M +$499M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 -$7.33M +$252K +3.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 -$7.58M +$86.9M +92% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$94.5M -$154M -259% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $59.5M +$54.2M +1038% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $5.22M -$70.3M -93.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $75.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q1 2012 -$1.85M -$1.13M -155% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-09
Q1 2011 -$728K -$68.7M -101% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q1 2010 $68M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06

IONIS PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $478M -$166M -25.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-19
2023 $644M +$699M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-19
2022 -$55.3M -$301M -122% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-19
2021 $246M +$843M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$597M -$697M -696% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $100M -$376M -79% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $476M +$247M +108% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $229M +$218M +1911% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $11.4M -$13.3M -53.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $24.7M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2011 -$672K -$5.37M -114% Jan 1, 2011 Dec 31, 2011 10-K 2012-02-29
2010 $4.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.